查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球肉毒桿菌市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測
市場調查報告書
商品編碼
1342778

全球肉毒桿菌市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

Global Botulism Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 167 Pages | 商品交期: 最快1-2個工作天內

價格

肉毒桿菌中毒是一種由針對人體神經的毒素引起的疾病。這是一種因食用受污染的食物而引起的食物中毒。該毒素是由肉毒桿菌產生的。當細菌孢子在新生兒腸道中發育時，這種疾病也會發生。肉毒桿菌中毒會減慢神經系統功能，如果長期忽視，可能會產生嚴重影響，包括死亡和癱瘓。肉毒桿菌中毒的常見症狀是噁心、便秘和復視。

市場動態：

隨著人們對不太激進的治療的渴望不斷成長，對肉毒桿菌的需求也在成長。影響肉毒桿菌市場的關鍵變量是肉毒桿菌引起的食物中毒的增加、有效肉毒桿菌治療的可用性以及政府的有利舉措是推動肉毒桿菌市場的主要因素。為了使肉毒桿菌療法合法進入市場並蓬勃發展，多家公司投資了研發項目。肉毒桿菌在製藥領域有著廣闊的市場。預計高昂的治療成本、嚴格的政府法規、重複產品和不準確的診斷將抑制肉毒桿菌市場的成長。

該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球肉毒桿菌市場的每個細分市場進行了包容性評估。肉毒桿菌產業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲肉毒桿菌市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。肉毒桿菌市場的主要參與者包括Alphavax Inc.、Ology Bioservices、Morphotek Inc.、Bausch Health Companies Inc.、Medytox、Molecular Targeting Technologies Inc.、蘭州生物製品研究所有限公司、Metabiologics Inc.、Merz Pharma、 Galderma SA、Revance Therapeutics Inc.、Emergent BioSolutions Inc.。本部分包含競爭格局的整體視圖，包括各種戰略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概覽、合作、新產品開發、新產品發布和其他開發。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第一章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：肉毒桿菌 - 行業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 行業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按類型分類的市場吸引力分析
    • 按治療類型進行的市場吸引力分析
    • 按配銷通路分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷管道發展趨勢

第 5 章：COVID-19 爆發的影響分析

第 6 章：全球肉毒桿菌市場分析：按類型

  • 按類型概述
  • 歷史和預測數據
  • 按類型分析
  • 食源性肉毒桿菌中毒
  • 嬰兒肉毒桿菌中毒
  • 傷口肉毒中毒
  • 吸入性肉毒桿菌中毒
  • 其他類型

第 7 章：全球肉毒桿菌市場分析：按治療類型

  • 按治療類型概述
  • 歷史和預測數據
  • 按治療類型分析
  • 抗毒素
  • 抗生素
  • 其他

第 8 章：全球肉毒桿菌市場銷售分析：按配銷通路

  • 按配銷通路分類的概覽
  • 歷史和預測數據
  • 按配銷通路分析
  • 醫院藥房
  • 零售藥店
  • 網路商店
  • 其他

第 9 章：全球肉毒桿菌市場銷售分析：按地理位置

  • 區域展望銷售分析
  • 簡介 銷售分析
  • 北美銷售分析
    • 概述、歷史和預測銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家/地區銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家/地區銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家/地區銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：肉毒桿菌公司的競爭格局

  • 肉毒桿菌市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 十大公司股票分析
  • 市場集中度
  • Alphavax Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Ology Bioservices
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Morphotek Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Bausch Health Companies Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Medytox
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Molecular Targeting Technologies Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Lanzhou Institute of Biological Products Co. Ltd.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Metabiologics Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Merz Pharma
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Galderma SA
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Revance Therapeutics Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Emergent BioSolutions Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內

Product Code: VMR11219897

Botulism is a sickness caused by a toxin that targets the body's nerves. It is a type of food poisoning caused by consuming contaminated food. The toxin is produced by the bacterium Clostridium botulinum. The illness can also develop when bacterial spores develop in new born's gut. Botulism slows down nervous system function and, if ignored for an extended period, can have severe effects, including death and paralysis. The common symptoms of botulism are nausea, constipation, and double vision.

MARKET DYNAMICS:

The demand for botulism has grown as there is a growing desire for less aggressive treatment. The key variables influencing the botulism market are the rise in food poisoning caused by botulism, the availability of effective botulinum treatments, and favourable initiatives by the government are the main factors driving the botulism market. For Botulism therapy to legally enter the market and thrive, several firms have invested in research and development projects. There is an excellent market for botulism in the pharmaceutical sector. It is projected that high treatment costs, strict governmental regulations, duplicative products, and inaccurate diagnoses would restrain the growth of the botulism market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of botulism. The growth and trends of botulism industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the botulism market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Foodborne Botulism
  • Infant Botulism
  • Wound Botulism
  • Inhalation Botulism
  • Other Types

By Treatment Type

  • Antitoxin
  • Antibiotics
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Stores
  • Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Botulism market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the botulism market include Alphavax Inc., Ology Bioservices, Morphotek Inc., Bausch Health Companies Inc., Medytox, Molecular Targeting Technologies Inc., Lanzhou Institute of Biological Products Co. Ltd., Metabiologics Inc., Merz Pharma, Galderma SA, Revance Therapeutics Inc., Emergent BioSolutions Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . BOTULISM - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Treatment Type
    • 3.7.3 Market Attractiveness Analysis By Distribution Channel
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL BOTULISM MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 Foodborne Botulism Historic and Forecast Sales by Regions
  • 6.5 Infant Botulism Historic and Forecast Sales by Regions
  • 6.6 Wound Botulism Historic and Forecast Sales by Regions
  • 6.7 Inhalation Botulism Historic and Forecast Sales by Regions
  • 6.8 Other Types Historic and Forecast Sales by Regions

7 . GLOBAL BOTULISM MARKET ANALYSIS BY TREATMENT TYPE

  • 7.1 Overview by Treatment Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Treatment Type
  • 7.4 Antitoxin Historic and Forecast Sales by Regions
  • 7.5 Antibiotics Historic and Forecast Sales by Regions
  • 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL BOTULISM MARKET SALES ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1 Overview by Distribution Channel
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Distribution Channel
  • 8.4 Hospital Pharmacies Historic and Forecast Sales by Regions
  • 8.5 Retail Pharmacies Historic and Forecast Sales by Regions
  • 8.6 Online Stores Historic and Forecast Sales by Regions
  • 8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL BOTULISM MARKET SALES ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook Sales Analysis
  • 9.2. Introduction Sales Analysis
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE BOTULISM COMPANIES

  • 10.1. Botulism Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF BOTULISM INDUSTRY

  • 11.1. Top 10 Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Alphavax Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Ology Bioservices
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Morphotek Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Bausch Health Companies Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Medytox
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Molecular Targeting Technologies Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Lanzhou Institute of Biological Products Co. Ltd.
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Metabiologics Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Merz Pharma
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Galderma SA
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. Revance Therapeutics Inc.
    • 11.13.1. Company Overview
    • 11.13.2. Company Revenue
    • 11.13.3. Products
    • 11.13.4. Recent Developments
  • 11.14. Emergent BioSolutions Inc.
    • 11.14.1. Company Overview
    • 11.14.2. Company Revenue
    • 11.14.3. Products
    • 11.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Type (USD MN)
  • Foodborne Botulism Market Sales by Geography (USD MN)
  • Infant Botulism Market Sales by Geography (USD MN)
  • Wound Botulism Market Sales by Geography (USD MN)
  • Inhalation Botulism Market Sales by Geography (USD MN)
  • Other Types Market Sales by Geography (USD MN)
  • Analysis Market by Treatment Type (USD MN)
  • Antitoxin Market Sales by Geography (USD MN)
  • Antibiotics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Online Stores Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Botulism Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Botulism Report
  • Market Research Process
  • Market Research Methodology
  • Global Botulism Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Treatment Type
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Foodborne Botulism Market Sales by Geography (USD MN)
  • Infant Botulism Market Sales by Geography (USD MN)
  • Wound Botulism Market Sales by Geography (USD MN)
  • Inhalation Botulism Market Sales by Geography (USD MN)
  • Other Types Market Sales by Geography (USD MN)
  • Global Market Analysis by Treatment Type (USD MN)
  • Antitoxin Market Sales by Geography (USD MN)
  • Antibiotics Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Online Stores Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.